Difficulty: Medium
Average Score: 88%
Practice
Indicate the antiparkinsonism drug which should be avoided in patients with glaucoma:
Correct answer
D
Rationale
The correct answer is D: Trihexyphenidyl. Trihexyphenidyl is an anticholinergic drug that can worsen glaucoma by causing pupil dilation, leading to increased intraocular pressure. This can exacerbate the condition and potentially cause vision problems. Selegiline (A) is a monoamine oxidase inhibitor used in Parkinson's disease but does not affect glaucoma. Levodopa (B) is a gold standard treatment for Parkinson's and does not directly impact glaucoma. Bromocriptine (C) is a dopamine agonist used in Parkinson's but does not have a significant effect on glaucoma. Thus, the correct choice to avoid in patients with glaucoma is Trihexyphenidyl due to its potential to worsen the condition.